Asian Journal of Cardiology Research

Cryptogenic Stroke with a Patent Foramen Ovale in a Patient with Pulmonary Embolism and Thrombophilia: A Case-based Discussion

Ghali Bennani *

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Soukaina Zahri

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Hanane Choukrani

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Salim Arous

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Ghali Bennouna

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Abdenasser Drighil

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Leila Azzouzi

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

Rachida Habbal

Department of Cardiology, University Hospital of Ibn Rochd, Casablanca, Morocco.

*Author to whom correspondence should be addressed.

---

Abstract

The patent foramen ovale (PFO) is a common abnormality that is often associated with cryptogenic stroke in young people. The management of PFO requires endovascular closure which prevents recurrence better than antithrombotic treatment. In the presence of concomitant thrombophilia, the risk of recurrence of stroke after closure of the PFO is increased, and one needs to institute antithrombotic therapy. The choice and duration of the treatment are controversial. Our study focuses on a 37-year-old patient admitted for ischemic vascular accident in whom a patent foramen ovale was found with an interatrial septal aneurysm (ASIA) on a ground of thrombophilia associated with a left pulmonary embolism and an occlusion. total left internal carotid artery.

Since at present, there is no optimal therapeutic strategy for these patients, the indications must be considered on an individual basis. The aim of the clinical case is to relate our experience in the management of cryptogenic stroke associated with PFO on a ground of thrombophilia.

Keywords: Cryptogenic stroke, patent foramen ovale, hypercoagubality, thrombophilia

---

---

---

References

Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W. et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J. Am. Coll. Cardiol. 2005;46(9): 1768–1776.

DOI: 10.1016/j.jacc.2005.08.038

Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164(9):950–956.

DOI: 10.1001/archinte.164.9.950

Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613–623.

DOI: 10.1016/S0735-1097(01)01427-9.

Roy S, Le H, Balogun A, Caskey E, Tessitore T, Kota R, Hejirika J, Yu S, Nguyen L, Lazo AL, Yard C. Risk of Stroke in Patients With Patent Foramen Ovale Who Had Pulmonary Embolism. Journal of Clinical Medicine Research. 2020;12(3):190.

Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-38.

Abdelghani M, El-Shedoudy SAO, Nassif M, Bouma BJ, de Winter RJ. Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: An Update. Cardiology. 2019;143(1):62-72.

Garg A, Thawabi M, Rout A, Sossou C, Cohen M, Kostis JB. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials. Cardiology. 2019;144(1-2):40- 49.

Hviid CVB, Simonsen CZ, Hvas AM. Recurrence Risk in Patients with Cryptogenic Stroke, Patent Foramen Ovale, and Thrombophilia: A Systematic Review and Meta-Analysis. Thromb Haemost. 2019;119(11):1839-1848.

Gerstein NS, Clegg SD, Levin DB, Fish AC, Tolstrup K, Nakanishi K, et al. A Case-Based Discussion on the Management of Cryptogenic Stroke and Patent Foramen Ovale in the Patient With a Hypercoagulable Disorder. J Cardiothorac Vasc Anesth. 2019;33(12):3476- 3485.

Sagris D, Georgiopoulos G, Perlepe K, Pateras K, Korompoki E, Makaritsis K, et al. Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis. Stroke. 2019;50(11):3135-3140.

Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236.